15-65384291-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020962.3(IGDCC4):c.3471C>A(p.Asp1157Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000687 in 1,455,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_020962.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGDCC4 | NM_020962.3 | c.3471C>A | p.Asp1157Glu | missense_variant | 20/20 | ENST00000352385.3 | NP_066013.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGDCC4 | ENST00000352385.3 | c.3471C>A | p.Asp1157Glu | missense_variant | 20/20 | 1 | NM_020962.3 | ENSP00000319623.3 | ||
IGDCC4 | ENST00000559327.1 | n.2740C>A | non_coding_transcript_exon_variant | 14/14 | 1 | |||||
IGDCC4 | ENST00000558048.5 | n.603C>A | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000812 AC: 2AN: 246310Hom.: 0 AF XY: 0.00000751 AC XY: 1AN XY: 133178
GnomAD4 exome AF: 0.00000687 AC: 10AN: 1455766Hom.: 0 Cov.: 35 AF XY: 0.00000691 AC XY: 5AN XY: 723804
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2024 | The c.3471C>A (p.D1157E) alteration is located in exon 20 (coding exon 20) of the IGDCC4 gene. This alteration results from a C to A substitution at nucleotide position 3471, causing the aspartic acid (D) at amino acid position 1157 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at